Rivera AB / Duse AG / Public Health Microbial Diseases Laboratory / Microbial Diseases Laboratory / XDR TB / 3Microbial Diseases Laboratory / /
Continent
Asia / /
Country
Switzerland / Mexico / Iran / Latvia / South Africa / Norway / United States / Vietnam / Korea / Philippines / China / South Korea / India / /
Currency
USD / / /
Event
M&A / Natural Disaster / /
Facility
TB laboratory / SAS Institute / University of California / /
IndustryTerm
State law / evaluable / /
MedicalCondition
United Extensively Drug-Resistant Tuberculosis / TB / JE / HIV / M. tuberculosis / Initial M. tuberculosis / Other Prior tuberculosis diagnosis Pulmonary disease / strain / protracted infectious period / XDR TB / MDR TB / infectious periods / DISCUSSION Although XDR TB / Mycobacterium tuberculosis infection / acquired XDR TB / extrapulmonary disease / cavitary lung disease / XDR-TB / Drug-Resistant Tuberculosis / HIV infection / extensively drugresistant tuberculosis / resistant tuberculosis / multidrugresistant tuberculosis / disease / Div. of Infectious Disease / ARTICLE Extensively Drug-Resistant Tuberculosis / Mycobacterium tuberculosis / pulmonary disease / XDR / Clinical Infectious Diseases / terminal illness / AIDS / cavitary disease / single XDR TB / Extensively Drug-Resistant Tuberculosis / multidrug-resistant Mycobacterium tuberculosis / each XDR TB / Tuberculosis / /
MedicalTreatment
antibiotics / directly observed therapy / /
Organization
World Health Organization / Division of Infectious Disease / Department of Pediatrics / Infectious Diseases Society of America / Centers for Disease Control and Prevention / SAS Institute / California Department of Public Health Microbial Diseases Laboratory / University of California / San Francisco / Department of Health / /
Person
MDR TB / Ritu Banerjee / Lisa Pascopella / Desmond E. Rapid / Henry F. Chambers / / /